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Abstract
Background: Bovine cysticercosis (BCC) (due to Taenia saginata) is often claimed to cause considerable economic
losses to the livestock industry, particularly in beef cattle, but recent studies estimating the economic impact are
lacking. The current study aimed to quantify the annual economic impact of BCC in Belgium from 2012 to 2016, by
gathering data from diverse sources in the meat and human health sectors.
Results: In Belgium, on average, 15 carcasses with generalised infections and 1168 carcasses with localised ones
are detected upon meat inspection each year. The highest proportion of the total economic losses due to bovine
cysticercosis were borne by the cattle owners with an average economic cost of €3,408,455/year: €2,954,061/year
due to BCC insurance, €453,024/year due to value losses of beef of uninsured carcasses (i.e. freezing process) and
€1370/year due to destruction costs of uninsured carcasses with generalised infections. The slaughterhouses
suffered an economic impact of €210,806/year. They were responsible for inspection costs related to meat
inspection in general, administration, processing and deboning of infected carcasses (€597,856/year), value losses
(€34,848/year) and destruction costs (€105/year) of carcasses insured by the slaughterhouses (unofficial insurance)
(5% of slaughtered animals). On the other hand, the slaughterhouses gained a total of €422,004/year due to
unofficial insurance fees. Thirty percent of all slaughtered animals were officially insured against BCC and the
insurance company generated an income of €2,322,337/year. The economic impact related to taeniosis (10,991
patients annually) amounted to a maximum of €795,858/year.
Conclusion: BCC and taeniosis due to T. saginata have a large economic impact in Belgium, mainly due to the
insurance costs for BCC. These results indicate the need for reducing the number of BCC and taeniosis cases to
avoid the costs and losses related to this parasite.
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Background
Taenia spp. are cestodes occurring worldwide, both in
low and high income countries. Taenia solium, the pork
tapeworm, causes severe human health problems, while
the other two species, Taenia saginata and Taenia asia-
tica, are of limited clinical importance but may inflict
considerable economic losses on the livestock industry
[1]. While T. asiatica has never been reported to occur
in Europe and T. solium is no longer endemic, infections
with T. saginata remain common [2]. The adult beef
tapeworm resides in the intestinal lumen of the human
final host (taeniosis), usually leading to only mild signs
and symptoms such as abdominal discomfort, mild
diarrhoea and weight loss. The most common symptom
of the disease is anal pruritus caused by the actively
migrating proglottids [2, 3]. People become infected by
consuming raw or undercooked beef containing viable
cysticerci, the metacestode larval stage found primarily
in the muscles of the bovine intermediate host (bovine
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cysticercosis, BCC) [4]. In the European Union, diagno-
sis of BCC in the slaughterhouses is based on official
meat inspection (MI) consisting of visual inspection of
the oesophagus, tongue, diaphragm and visible muscle
surfaces and incisions made in the heart and masseter
muscles (EC Regulation 854/2004). The estimated preva-
lence of BCC in Belgium, based on MI, was reported to
be 0.23% [5–9], yet official figures for prevalence tend to
be underestimations [10–13] as MI is known to have a
low sensitivity.
It is generally assumed that BCC is responsible for im-
portant economic losses in the meat sector, particularly
for beef cattle [1, 14, 15]. EC regulations dictate that car-
casses diagnosed with generalised/heavy BCC (i.e. multiple
cysticerci found during MI) are condemned and
destroyed, while those with localised/light infections (only
one or a few cysticerci found during MI) must be frozen
(at least 10 days at -18 °C) prior to consumption (EC
Regulation 854/2004). Freezing of beef substantially de-
creases the value (30–45%) [16]. Overall, however, there is
a lack of recent studies estimating the economic impact of
BCC and taeniosis in Europe [3]. A review by Murrell [17]
estimated the value loss for a carcass due to bovine cysti-
cercosis at US $234/carcass and medical costs for taeniosis
at US$ 111/patient in industrialised countries in 1990. In
England, costs due to BCC were estimated at GB £100/
carcass or GB £4.0 million annually in 1999 [18]. In
Belgium, the economic impact was estimated at €600,000
(24,262,400 Belgian franc) in 1987, including consultations
and medication costs for patients (€12.5/patient) and
value losses for bovine carcasses (€620/carcass) [16]. The
current study aimed to provide an updated estimate of the
annual economic impact caused by T. saginata in Belgium
for the meat and the human health sectors, based on re-
cent data (2012–2016).
Methods
Study site/population
The economic impact due to T. saginata was estimated
for the reference period 2012–2016 in Belgium, an
industrialised country with an estimated 11,348,160 in-
habitants in 2016 [19]. An average of 511,528 adult cat-
tle and 340,221 calves are slaughtered in the country on
a yearly basis [5–9].
Collection of information from the animal/meat sector
and official veterinary services
Official information regarding the average number of
carcasses with generalised (15 animals) and localised
[1168.2 animals (abbreviated for calculations to 1168)]
cysticercosis per year, based on routine meat inspection,
was collected from the Annual reports of the Federal
Agency for the Safety of the Food Chain (FASFC) [5–9].
For BCC positive carcasses, additional information was
gathered (sex, birth date, slaughter date, slaughter weight
and slaughterhouse) by personal communication with
FASFC. All BCC positive carcasses were found to origin-
ate from adult cattle, therefore all further estimations
were based on adult cattle data. The value (€/100 kg) of
beef (per week) according to the SEUROP classification
(carcass classification defined by the European Union) and
subdivided into bulls, cows and heifers, was available on the
website of the Department of Agriculture and Fisheries
[20]. The SEUROP classification subdivides cattle carcasses
into quality categories depending on the conformation of
the carcass (S = superior; E = excellent; U = very good; R =
good; O = average; and P = low) [21].
A single animal carcass destruction company is
present in Belgium and was contacted for information
on the destruction costs of carcasses with generalised in-
fections. Burning of carcasses costed €187.67/ton and
transport to the burning facility costed €50/hour.
Furthermore, Belgium has one official insurance com-
pany for BCC and information about the insurance pol-
icy and the cost of the insurance fee was provided by its
owner. Approximately 30% of all bovines were insured
through the official insurance company, prior to slaugh-
ter (mostly beef cattle). The insurance fee was between
€8–25, depending on the number of animals insured by
the same animal owner (administrative costs diminished
with an increasing number of insured animals). Apart
from BCC, the insurance also covered sarcosporidiosis,
so the true cost for BCC insurance specifically was not
known. In some slaughterhouses, it was also possible to
obtain an unofficial insurance. Information concerning
this system was gathered from the president of the Pro-
fessional Association of Flemish Cattle dealers and Meat
producers (VVV). The unofficial insurance fee was
within the same price range as the official one and ap-
proximately 5% of animals were unofficially insured at
the slaughterhouses (mostly beef cattle).
Information on (i) the inspection costs, (ii) the time
inspectors at the slaughter houses need for proceedings
related to BCC, as well as (iii) the value loss of beef due
to freezing, was obtained from FASFC, the insurance
company, the Belgian Meat Federation (FEBEV) and a
questionnaire sent to all slaughterhouses in Belgium.
Eight of 36 slaughterhouses replied and answers were
formulated by meat inspectors or other contributors of
the slaughterhouses. The time an inspector needs for the
proceedings related to BCC can be divided into three
components: (i) the time during meat inspection ad-
dressed specifically to cysticercosis; (ii) the time neces-
sary for preparing the carcasses for shipment to the
freezing, deboning or destruction facilities (including ad-
ministration) (this is defined further as ‘processing’ and
is done by the inspector himself ); and (iii) the deboning
process taking place before freezing of the carcasses with
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localised infections during which an inspector needs to
be present. The information gathered from these sources
was combined and validated through discussion with ex-
perts at the FASFC. The inspection fee, which slaughter-
houses are obliged to pay to FASFC for the presence of
meat inspectors during slaughtering, was rated at €75/
hour. The time attributed specifically to the detection of
cysticercosis was estimated between 15–60 seconds (s)/
carcass. In case a cysticercosis positive carcass was de-
tected (generalised or localised), the time needed to
complete the administration involved and the supervi-
sion during the preparation for shipment to the de-
boning, freezing or destruction facilities (processing) was
estimated at 30–90 minutes (min)/ carcass. Carcasses
with localised infections were deboned under supervi-
sion of an inspector and parts were frozen separately.
The deboning process took between 60–90 min/carcass.
The value loss of a frozen carcass is currently estimated
to range between 40–70%. This percentage includes the
costs associated with the freezing process, the transport
to the freezing facility and the weight loss of the carcass/
beef due to freezing. Although the deboning process in-
troduces an additional inspection cost, the process itself
will reduce the total value loss, as a complete carcass
needs a significant amount of time to thaw and needs to
be processed immediately. When a carcass is deboned
prior to freezing, thawing is faster and processing of the
meat is much easier and more efficient. Carcasses with
generalised infections are condemned and their total
value is lost.
Collection of information from the human health sector
Taeniosis is not a notifiable disease in Belgium. There-
fore, prevalence was estimated from the sales numbers
of taenicidal drugs [2]. In Belgium, the prescribed drug
for taeniosis is niclosamide, produced and commercial-
ized as ‘Yomesan®’. Over the last five years, on average
10,991 patients were treated per year (personal commu-
nication Bayer Pharma AG). The price for one dose of
Yomesan® was €6.29 [22]. We assume all patients re-
ceived treatment.
No information was gathered about the proportion of
patients with a suspected tapeworm who consulted a
physician. We assumed that patients consulting a phys-
ician would generally have a follow-up appointment en-
suring the treatment was successful. In general, a single
consultation had a cost of €25 for the patient, of which
€21 was reimbursed by the health care sector (expert
opinion). Patients with special reimbursement schemes
were not accounted for in the estimations. Since Belgian
phycisians rarely encounter a patient with a tapeworm
(personal communication physicians), we chose for the
worst-case scenario and assumed that all physicians filed
for a diagnostic test. One test costs €16.12 and is paid by
the patient (personal communication, Institute of Trop-
ical Medicine Antwerp).
Analyses
A model was written in the R programming language
(R Core Team, 2014), combining the information de-
scribed above, to calculate the economic burden of BCC,
and more specifically the value losses suffered from in-
fected carcasses, inspection costs, destruction costs for
carcasses with generalized infections, insurance costs and
costs related to human health (see below). The model per-
forms the calculations for the economic impact as follows.
Estimation of value losses suffered from infected carcasses
The data for the cysticercosis positive carcasses with
localised infections (5841 animals) obtained during the
study period (personal communication FASFC) con-
tained missing values. For six animals, the exact slaugh-
ter date was missing and only the year of slaughter was
provided. We chose to replace the missing value with
the first of July of the year of slaughter (mid-year). Miss-
ing weight data (20 animals) were replaced with the
average weight calculated from all other positive car-
casses. Animals with missing sex values (838) were ex-
cluded from further calculations. Therefore, information
for a total of 5003 carcasses with localised infections was
used for calculating the value loss. For carcasses with
generalised infections (74 animals), the same substitu-
tions were made for missing values of weight (one ani-
mal) and slaughter date (one animal). Expert opinion
was used to determine the class (SE, UR or OP) of each
cysticercosis positive carcass between 2012 and 2016
(Fig. 1). The code obtained for each animal was linked
to the corresponding beef value to assign the corre-
sponding value to each carcass [20]. Monthly, instead of
weekly, average beef values were calculated and an aver-
age value was calculated for the S and E classes com-
bined (SE), U and R classes combined (UR) and O and P
classes combined (OP).
Expert opinion indicated that slaughter yield ranged be-
tween 55–70% for Belgian cattle [23, 24]. We chose an
average slaughter yield of 62.5% for estimating the cold
carcass weight from the slaughter weight. The total value
of each carcass was calculated using the cold carcass
weight and the assigned value for beef. For carcasses with
generalised infections, the entire value of the carcass was
lost. Carcasses with localised infections needed to undergo
freezing and the value loss due to freezing depended on
the value of the beef. Losses were lower for high value beef
than for low value beef (e.g. dairy cattle) (personal com-
munication FASFC, insurance company, FEBEV and
slaughterhouses). To determine the value loss, we
assigned the lowest percentage value loss (40%) to the
most valuable carcass in the data and the highest
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percentage value loss (70%) to the least valuable carcass.
All carcasses with values in between received percentage
value losses respective to their estimated value by linear
interpolation. The actual value loss was calculated by
multiplying these percentages by the total carcass value.
The individual value losses were summed, divided by the
sample size and multiplied by the annual number of cysti-
cercosis cases to calculate an average total value loss per
year for Belgium.
Estimation of inspection costs
The average time, based on the estimated time limits, was
used to determine the time spent on each carcass for
searching for BCC during meat inspection (37.5 s/carcass)
, for processing the infected carcasses (60 min) and for de-
boning the localised infected carcasses (75 min) (personal
communication FASFC, insurance company, FEBEV and
slaughterhouses). Cost per carcass was estimated by multi-
plying these values by the inspection fee (€75/hour) (per-
sonal communication FASFC, insurance company, FEBEV
and slaughterhouses). The annual costs for these pro-
cesses were estimated by simply multiplying the previous
estimates by the number of animals in the population
(slaughtered cattle for ‘MI’, all infected carcasses for ‘pro-
cessing infected carcass’ and carcasses with localised infec-
tions for ‘deboning’).
Estimation of destruction costs for carcasses with
generalised infections
For the annual costs due to the destruction of generalised
infected carcasses, their average annual weight over the
study period (personal communication FASFC) was multi-
plied by the cost of destruction (€187.67/ton) (personal
communication destruction company). To estimate costs
of transport of infected carcasses, the average annual dis-
tance (km) was calculated based on the fastest route from
the slaughterhouses in which the respective positive car-
casses were found, to the destruction facility. This value
was used to determine the duration of transport, based on
an average speed of 60 km/h, and consequently the cost of
transport. The route chosen was probably not the actual
route taken by the driver since multiple pick-ups could
have been combined in one drive and transportation costs
were most likely divided amongst pick-up places. How-
ever, it remains the best estimate possible for the total cost
for the transport to the destruction facility.
Estimation of insurance fee
An average annual cost was calculated for all officially
and unofficially insured animals, using information
about the proportion of animals that are officially (30%)
and unofficially (5%) insured prior to slaughter and the
average cost for the insurance (€16.5) (personal commu-
nication insurance company, VVV).
Fig. 1 Flowchart for class determination of each individual animal. Abbreviations: SE, S and E class; UR, U and R class; OP, O and P class; Fem,
female; Mal, male; y, years
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Estimation of costs related to human health
Given the lack of information on the proportion of pa-
tients consulting a physician with a suspected tapeworm
infection, values between zero and one (using incre-
ments of 0.1) were used for this variable in the model
and calculations were made for all possible values. The
annual cost for consultations was estimated by multiply-
ing the number of taeniosis cases (10,991; based on sale
of ‘Yomesan®’) by the proportion of people consulting a
physician, the number of consultations per patient (two)
and the cost of a consultation for both patients (€4) and
the health care system (€21).
The total cost for diagnostic tests was calculated by
multiplying the number of taeniosis cases by the as-
sumed proportion of patients that go to a physician, the
proportion of physicians ordering diagnostic tests (one)
and the cost of the diagnostic test (€16.12) (personal
communication, Institute of Tropical Medicine). The
cost for the drug was estimated by multiplying the num-
ber of taeniosis cases by the price of ‘Yomesan®’ (€6.29)
[22], assuming all patients received treatment.
Results
Animal/meat sector
The average annual estimated costs for the meat sector can
be found in Table 1. The annual economic impact for BCC
for the reference period 2012–2016, estimated in this study,
was interpreted with respect to the different parties in-
volved: the animal owners, the slaughterhouses and the in-
surance company (Table 2). The insurance company (30%
animals insured) and the slaughterhouses (5% animals in-
sured) were responsible for the value losses and destruction
costs of the insured animals. The same costs were borne by
the animal owner for the uninsured animals.
Human health sector
Figure 2 shows the costs for the human health sector, for
each value assigned to the proportion of patients consult-
ing a physician between zero and one. Annual drug costs
were independent of the proportion of people consulting
a physician and amounted to €69,133 (Fig. 2, red line). If
all patients with taeniosis were to consult a physician, the
consultation costs would amount to a maximum of
€87,928 and €461,622 for patients (Fig. 2, purple line) and
for the human health care system (Fig. 2, green line), re-
spectively, and to a maximum of €177,175 for diagnostic
tests (Fig. 2, blue line). In total, this means that the annual
cost for the human health care sector varies from €69,133
(€6.29/patient) in case no patients consult a physician, to
€795,858 (€72.4/patient) if all patients consult a physician,
all physicians request a diagnostic test and all patients
consult the physician again for confirmation of successful
treatment (Fig. 2, black line).
Discussion
We quantified the economic impact of T. saginata in
Belgium in a comprehensive way for both the animal/
meat sector and the human health sector. The highest
economic cost was borne by the animal owners, with a
total annual cost of €3,408,455, mostly due to insurance
fees. Slaughterhouses suffer a substantially smaller loss
of €210,806/year. This number is an average value for all
Belgian slaughterhouses combined. However, not all
slaughterhouses offer the unofficial insurance for BCC
to cattle owners, so they will not generate an income to
Table 1 Summary of the estimated annual costs related to bovine cysticercosis in Belgium: value loss, costs related to inspection at
the slaughterhouses, costs related to the destruction of carcasses with generalised infections and insurance costs
Category of cost Type of cost €/year €/unit of interest
Value loss Generalised infections 12,874 (€858/carcass generalised infection)
Localised infections 684,087 (€586/carcass localised infection)
Total value loss 696,961
Inspection Meat inspection 399,631 (€0.78/slaughtered animal)
Processing infected carcass 88,725 (€75/infected carcass)
Deboning carcasses with localised infection 109,500 (€93.75/carcass localised infection)
Total inspection cost 597,856
Destruction Destruction cost 1023 (€68.2/carcass generalised infection)
Transport to destruction facility 1084 (€72.3/carcass generalised infection)
Total destruction cost 2107 (€140.5/carcass generalised infection)
Insurance Officially insured animals 2,532,057 (€16.5/insured animal)
Unofficially insured animals 422,004 (€16.5/insured animal)
Total insurance cost 2,954,061
Total 4,250,985
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compensate for losses. Some slaughterhouses will co-
operate directly with the official insurance company and
insure all animals entering the slaughterhouse. The bal-
ance between loss and income thus varies between
slaughterhouses.
The value loss per carcass was estimated for industrial
countries in previous studies: €620 (25,000 Belgian
franc) per carcass for Belgian cattle (in 1987) [16], €198
(US$ 234) per carcass for cattle in industrialised coun-
tries (in 1990) [17] and €113.6 (GB£ 100) per carcass in
the United Kingdom (1999) [18]. Our current estimate
(€586/carcass) is higher than the estimates made for
industrialised countries and the UK, but lower than
the estimate for Belgium originating from 1987. This
previous estimate was a rather rough estimate based
on the average value of all slaughtered cattle, and not
considering solely the BCC positive animals (as was
done in the current study). In Belgium, high value
carcasses (e.g. Belgian Blue breed) are easily worth
€2500, whereas the average annual value of an in-
fected carcass was estimated to be €1073 in the
current study period. The lower average value loss
found in the current study indicates that BCC infec-
tions are mainly found in low value carcasses. In the
Belgian livestock industry, low value carcasses are
mostly culled dairy cows. The occurrence of BCC has
been positively correlated with increasing age and be-
ing female [11, 25–28].
The percentage value loss per carcass was always con-
sidered to be between 30–45% [16], yet has now in-
creased to between 40–70% (personal communication
FASFC, insurance company, FEBEV and slaughter-
houses). This is most likely due to an increase in the
costs related to the freezing process. Comparison with
the UK and industrialised countries estimates is more
realistic and shows an important increase in value loss
per carcass during the last 20–30 years.
Table 2 Summary of the estimated annual losses (negative
values) and income (positive values) related to bovine
cysticercosis in Belgium for the animal owners, the
slaughterhouses and the insurance company
Sector Category of cost €/year
Animal owner Insurance -2,954,061
Value loss -453,024
Destruction -1370
Total -3,408,455
Slaughterhouses Insurance 422,004
Value loss -34,848
Destruction -105
Inspection -597,856
Total -210,806
Insurance company Insurance 2,532,057
Value loss -209,088
Destruction -632
Total 2,322,337
Fig. 2 Costs related to consultations for patients and for the human health care system, costs for drugs, diagnostic tests and the total costs,
relative to the proportion of patients consulting a physician
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Our study had some limitations. While collecting data,
extensive information for some parameters could not be
obtained, so distributions could not be included in the
model for these parameters. Slaughter yield is between
55–70% for Belgian cattle (with exceptions), depending
on the breed/physique of the animal (dairy/beef ), the
stomach content, the conformation, the fatness, the
bone structure, the feed received during life, age, weight,
the methods used for deboning and the slaughter weight.
Many of these factors were unknown for the infected
carcasses so we chose an average slaughter yield of 62.
5% for our estimations of value loss [23, 24]. The time
spent searching for BCC during meat inspection and the
time for processing and for deboning of infected car-
casses was obtained from various sources (personal com-
munication FASFC, insurance company, FEBEV and
slaughterhouses), allowing us to identify a range of pos-
sible values. There were no indications as to what time
value might be the most probable. The same is true for
the cost of the insurance for each animal, which depends
on many factors that were not specified per animal by
the insurance company. Therefore, the average value
was used for these parameters.
Inconsistencies were uncovered between the official num-
ber of cysticercosis cases and the number of cysticercosis
cases provided by the owner of the insurance company [e.g.
amongst the insured animals (30% of all slaughtered ani-
mals), 21 animals with generalised infections were reported
in 2013, while there were only 16 according to official re-
cords in the total population]. Other common differential
diagnoses such as abscesses, Sarcocystis infections or granu-
lomas [29] could lead to misdiagnosis and misclassification
of some animals during the administrative process, making
it difficult to retrieve correct information about cysticerco-
sis. This might indicate that the numbers of the insurance
company were an overestimation of the total BCC numbers
or that the official numbers were an underestimation. If the
latter is true, estimations made for the economic impact in
this study were also an underestimation. When extrapolat-
ing the numbers received by the insurance company to an-
nual averages, there would be 63.5 carcasses with
generalised infections (based on data from 2013 until the
end of 2016) and 1406 carcasses with localised infections
(based on data from 2016) per year. With these higher
numbers of infected carcasses, the annual cost for the ani-
mal owner would increase to €3,530,547 (compared to
€3,408,455), the costs for the slaughterhouses would in-
crease to €263,996 (compared to €210,806) and the insur-
ance company would have an income of €2,282,337
(compared to €2,322,337). These higher estimates did not
reveal a substantial increase in the economic impact. Even-
tually, irrespective of the scenario, the largest proportion of
the economic losses suffered will be borne by the cattle
owners.
As previously mentioned, the official insurance policy
includes an insurance against sarcosporidiosis and for
the unofficial insurance, it is not clear which conditions
are being covered by the policy. Therefore, it is not clear
which proportion of the insurance fee is attributed to
cysticercosis. However, the number of sarcosporidiosis
cases (currently 85 cases/year, personal communication
FASFC) is much lower than the number of cysticercosis
cases so the estimate based on the entire insurance fee
remains the best possible estimate, even though it is an
overestimation.
The costs related to the human health sector consti-
tute a much smaller portion of the total economic im-
pact compared to the animal/meat sector, yet imply an
maximum annual cost of €795,858, including consulta-
tions, diagnostic tests and medication. For these esti-
mates, the assumption was made that all patients will
have a follow up consultation and all physicians will de-
mand a diagnostic test for each patient. These assump-
tions might be overestimations compared to the real
situation but it was not within the limits of this study to
gather exact data for these parameters.
The drug used for taeniosis, Yomesan®, is not 100% ef-
fective [30], so some patients might need an extra dose
to expel the tapeworm. Yomesan® can also be used
against other tapeworm infections such as T. solium and
Diphyllobothrium latum, but those infections are non-
endemic and very rarely diagnosed in Belgium ([31, 32]
Potters, I., Institute of Tropical Medicine, personal com-
munication). Praziquantel, commonly used in neighbour-
ing countries for treatment of taeniosis, is not available in
Belgium in regular pharmacies and is therefore not pre-
scribed for taeniosis. Mebendazole (‘Vermox®’) is available
without prescription in regular pharmacies and may erro-
neously be sold by pharmacists to taeniosis patients when
they suspect a nematode infection (mostly Enterobius ver-
micularis). However, the recommended dose of Mebenda-
zole for curing taeniosis is three times higher than for E.
vermicularis. A single Mebendazole dose is likely to be in-
efficient for taeniosis and patients will require another
treatment. It is not known how many patients received
Mebendazole for treatment of taeniosis. Due to this lack
of knowledge and since the drug sales numbers of Yome-
san® are generally used to estimate the annual number of
taeniosis patients [33], this method was considered the
best option.
The cost per taeniosis patient was estimated in 1987
to be €12.5 in Belgium (including consultations and
medication) [16]. This cost has increased to €56.3 in the
current study (only including consultations and medica-
tion for comparison). The estimate made by Murrel [17]
for industrialised countries of US$ 111/patient also in-
cluded the possible wage loss a patient might experience
due to a tapeworm, by consulting a physician or hospital
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or for the time they are unfit for work (€93.8/patient).
This was not estimated in the current study.
Several factors listed below can be considered as a cost
related to BCC or taeniosis but were not included in the
calculations since they were either rare, case-depending or
implied a very small proportion of the total cost. However,
they would even further increase the economic impact of
the parasite on the animal and human health sector.
 The animal owner of a positive carcass can make
the personal decision to take several actions that can
lead to additional costs: official or private
veterinarians could perform further investigations on
the remaining animals on the farm, attempt to trace
the infection or give advice on how to prevent
further infections, farm workers could be tested for
T. saginata infection and informed on how to
handle this infection, and new measures for the
prevention of infections could be implemented (e.g.
water filters).
 Veterinarians performing the meat inspection at the
slaughterhouses regularly attend training sessions
and continue professional education, and
slaughterhouses are frequently audited.
 Research projects exploring all aspects of the
parasite/disease need funding.
 Examples exist of non-specific complications asso-
ciated with T. saginata infection in humans (e.g.
cholangitis, peritonitis, post-appendectomy fecal
fistula) [34–36], including a possible need for a
hospitalization. In Belgium, this is extremely rare.
According to official data, in 2010 and 2014 none
and in 2008, 2009, 2011, 2012 and 2013 less than
five patients were hospitalised with T. saginata as
a primary diagnosis and without indication of se-
verity. No data were available for 2015 and 2016.
These data are not always correct and the distinc-
tion between T. saginata and other Taenia spp. is
not always made [31]. Psychological stress of pa-
tients due to the presence of a tapeworm could
cause additional costs not included in the
analysis.
 In many studies on economic burden, transportation
costs to and from the physician and pharmacy are
included. In Belgium, medical practices and
pharmacies are present in every village, making
these costs negligible.
 Sewage is treated before wastewater enters the
waterways. Sadly, current wastewater management
not only fails to halt, but rather contributes to the
dissemination of eggs in the environment, leading to
contaminated waterbodies and surface water [2].
Sewage sludge is no longer used in agriculture to
fertilize pastures in Belgium, but in other European
countries it is still allowed and can pose a higher
risk for cattle [37].
 For many diseases, part of calculating the burden of
disease is to quantify health losses using Disability-
adjusted life years (DALYs). One DALY is defined as
one lost year of healthy life. For taeniosis caused by
T. saginata, the DALY is probably very low, since
most infections remain asymptomatic. For those few
patients that will experience mild abdominal pain,
DALYs can be estimated to be 0.012/year, which is
still very low [38].
Meat inspection is known to have a low sensitivity and
a recent study in Belgium found a much higher preva-
lence (36%) of BCC than previously thought, using a
combination of several detection techniques (MI, dissec-
tion of the predilection sites, B158/B60 Ag-ELISA and
excretory/secretory Ab-ELISA) [13]. Undetected viable
cysticerci can enter the food chain and potentially cause
taeniosis in humans when they eat raw or undercooked
beef. Introducing a new and more sensitive detection
technique at slaughter might be one way of reducing the
number of cysticerci in the food chain. This would imply
that more carcasses are condemned or need to be frozen
after slaughter, introducing a higher cost at first, but
leading to a reduction in the number of taeniosis pa-
tients, subsequently in the number of cattle with cysti-
cerci and eventually in the total economic impact due to
BCC and taeniosis. A model assessing new detection
techniques and their impact on prevalence of cysticerco-
sis and taeniosis and the economic impact in Belgium is
currently being developed by the authors of this study.
Human tapeworm carriers are essential for mainte-
naining transmission, therefore, the responsibility of
the medical sector and general population in the con-
trol of this parasite should not be neglected. People
should be made aware of the risk they pose towards
cattle when eating raw or undercooked beef and devel-
oping a tapeworm. There is an urgent need within the
medical sector for information campaigns for physi-
cians and patients on how to treat patients and how to
correctly dispose of the expelled tapeworm, in order to
reduce the infection risk for cattle and the economic
impact on cattle owners.
Conclusions
In conclusion, BCC and taeniosis due to T. saginata
cause a relatively large economic impact in Belgium, es-
pecially due to the insurance costs for BCC, borne by
the farmers. These results demonstrate the need to re-
duce the number of BCC and taeniosis cases to, in turn,
avoid or reduce the costs and losses related to this para-
site for the animal and human health sectors.
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